Arrowhead Pharmaceuticals, Inc. ARWR

65.92 (0.15) (0.23%) as of 25 Sep
Market cap
$9.3B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21 Sep '22 Sep '23 Sep '24 Sep '25
Cash and Short Term Investments
85.37 65.61 76.53 258.70 315.49 367.79 376.40 403.63 680.96 919.37
Receivables
0.08 0.07 0.33 0.66 0.85 10.26 1.41 — — 6.82
Other current assets
3.77 1.36 0.64 2.56 1.78 2.19 20.20 4.03 4.97 13.52
Total current assets
90.50 67.90 78.77 265.25 322.37 384.60 405.30 416.47 695.47 950.64
Property, Plant, Equpment (Net)
15.39 15.51 13.94 23.21 30.88 48.68 110.30 290.26 386.03 382.52
Long-Term Investments
— — — 44.18 137.49 245.60 105.87 — — —
Goodwill and Intangible Assets (Total)
22.16 20.46 18.76 17.06 15.36 13.66 11.96 10.26 8.56 6.86
Long-term assets (Other)
0.12 0.14 0.14 0.14 0.26 0.27 0.22 3.26 4.48 1.39
Total non-current assets
37.67 36.12 32.84 84.60 200.13 325.55 286.64 349.08 444.33 434.66
Total Assets
128.18 104.02 111.61 349.85 522.50 710.15 691.94 765.55 1,139.80 1,385.30
Notes Payable
0.19 0.21 0.22 — — — — — — —
Accounts Payable
12.23 4.08 2.81 7.65 6.83 9.46 2.87 35.87 11.39 17.67
Accrued Expenses
8.56 7.96 8.98 11.46 13.45 23.77 59.11 57.73 85.01 117.31
Current Part of Debt
0.19 0.21 0.22 — 1.09 2.25 2.78 10.56 — 40.00
Current Revenue (Deferred)
3.01 5.71 0.31 77.94 19.29 111.06 74.10 0.87 0.00 2.40
Other current liabilities
1.65 0.74 0.05 0.02 0.02 134.83 133.21 0.44 0.43 10.81
Total current liabilities
25.64 18.70 12.37 97.07 40.68 146.54 138.85 105.46 103.17 195.49
Long Term Debt (Total)
2.53 2.33 2.10 — 20.04 23.30 78.80 372.93 393.18 214.88
Non-current Revenue (Deferred)
4.78 1.93 1.70 8.74 0.00 131.50 55.95 — — —
Non-current Liabilities (Other)
0.20 0.20 0.20 3.70 — — — 268.33 341.36 367.40
Total non-current liabilities
7.51 4.45 4.00 8.74 20.04 154.79 134.75 372.93 845.57 686.39
Total liabilities
33.15 23.16 16.37 105.81 60.73 301.33 273.60 478.39 948.74 881.88
Additional Paid In Capital
493.84 514.04 582.90 664.09 965.41 1,053.39 1,219.21 1,300.40 1,806.00 2,139.73
Preferred Stock (Total)
0.00 — — — — — — — — —
Common Stock (Net)
0.16 0.17 0.18 0.19 0.20 0.20 0.20 0.20 0.22 0.23
Retained Earnings
(398.43) (432.82) (487.27) (419.29) (503.84) (644.69) (820.75) (1,026.03) (1,625.52) (1,627.15)
Treasury Stock
— — — — — — — — — 53.19
Common Equity (Total)
95.02 80.87 95.24 244.04 461.78 408.82 418.34 287.16 191.06 503.42
Shareholders Equity (Total)
95.02 80.87 95.24 244.04 461.78 408.82 418.34 287.16 191.06 503.42
Shareholders Equity and Liabilities (Total)
128.18 104.02 111.61 349.85 522.50 710.15 691.94 765.55 1,139.80 1,385.30
Shares (Common)
69.75 74.79 88.51 95.51 102.38 104.33 105.96 107.31 124.38 135.70
Shares (Preferred)
0.02 — — — — — — — — —
Shareholders Equity (Tangible)
72.86 60.40 76.48 226.97 446.42 395.16 406.38 276.90 182.50 496.56
Net Debt
(82.64) (63.07) (74.21) (258.70) (294.35) (342.24) (294.82) (20.13) (287.78) (664.48)
Total Debt
2.73 2.53 2.33 — 21.14 25.55 81.58 383.50 393.18 254.88

Fold the line items

In millions of $ except per-share values · columns are period end dates